ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 55 filers reported holding ADICET BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $378,599 | -5.9% | 65,729 | +46.1% | 0.52% | +104.3% |
| Q4 2022 | $402,300 | -37.1% | 45,000 | 0.0% | 0.26% | -0.8% |
| Q3 2022 | $640,000 | -77.8% | 45,000 | -77.3% | 0.26% | -64.9% |
| Q2 2022 | $2,889,000 | -26.9% | 197,898 | 0.0% | 0.74% | -10.7% |
| Q1 2022 | $3,952,000 | +14.2% | 197,898 | 0.0% | 0.82% | +40.8% |
| Q4 2021 | $3,461,000 | +123.0% | 197,898 | 0.0% | 0.59% | +392.4% |
| Q3 2021 | $1,552,000 | -36.0% | 197,898 | -16.1% | 0.12% | +32.2% |
| Q2 2021 | $2,426,000 | -22.7% | 235,748 | -1.8% | 0.09% | -23.1% |
| Q1 2021 | $3,139,000 | – | 240,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |